galectin-9 dual action bone agent (BIOCND)

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug Namegalectin-9 dual action bone agent (BIOCND)
Drug Alias Namegalectin-9-based DABA (BIOCND)galectin-9-based DABA (Galpharma)galectin-9 dual action bone agent (Galpharma)BCD-230BCD-220 +[6] 
ClassificationSmall molecules
Mechanisms of ActionBone synthesis stimulantsBone resorption inhibitors
TargetsUpdating
Therapy Area/IndicationsDermatitis, AtopicOsteoporosis, PostmenopausalCommunicable Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth KoreaJapan
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesGalPharma Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesPharmaResearch Co LtdGalPharma Co Ltd
Active IndicationsN/A
Inactive IndicationsDermatitis, AtopicOsteoporosis, PostmenopausalCommunicable Diseases

Other Information

ATC CodeN/A
Related LinksN/A